Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
News
Nature Medicine  7, 517 (2001)
doi:10.1038/87813

PCs enlisted to cure cancer

John MacFarlane

London

http://www.ud.com/cancer

Cure cancer during your coffee break, crack protein folding while you're at lunch, evaluate AIDS drugs as you chat on the phone. Every time you step away from desk, your computer sits idle, but network your humble PC with thousands or millions of others through the Internet and a virtual supercomputer emerges. This is the power of distributed, or peer-to-peer (P2P), computing, and the potential benefits of using this spare computing power means that researchers are vying for the use of your PC.

The latest P2P project—a collaboration between Oxford University's Centre for Computational Drug Discovery, the National Foundation for Cancer Research, distributed computing specialist United Devices and Intel—aims to find drug candidates for treating leukemia. The project's program THINK runs as a screen saver and tests binding interactions between selected target proteins, including superoxide dismutase and vascular endothelial growth factor, against a bank of small molecule drug candidates. Interactions are logged and sent back to the researchers for follow-up, reducing millions of potential drug leads to around 200,000 candidates.

Project-leader Graham Richards, Chairman of Chemistry at Oxford University, claims that even if using a traditional supercomputer, "a researcher could not hope to see a project like this completed during their lifetime." But to succeed, the general public must download and run the software. Richards says that the response so far has been "absolutely staggering". In the first week of the project, 200,000 individuals have signed up, and software downloads have at peak times reached three per second. This has already allowed the team to increase the number of drug candidates they plan to screen from 250 million to 800 million.

Other P2P networks aimed at combating disease include Entropia's FightAIDS@home, and Intel plans to develop similar programs for Parkinson disease and diabetes. Richards put the success of THINK down to simple program design which participants can easily understand, and perhaps more importantly to peoples' personal connection with cancer. "One in four people throughout the world contract some form of cancer, so nearly everyone will have a relative, friend or colleague who has suffered, or is suffering from the disease. People now have the opportunity to make a positive impact on the disease by donating their unused computer power," he says.

 Top
FULL TEXT
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

naturejobs

Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2001 Nature Publishing Group | Privacy policy